Carbomer and ethyl cellulose optimisation in the preparation of mucoadhesive microspheres ciprofloxacin hydrochloride
DOI:
https://doi.org/10.46542/pe.2023.234.2731Keywords:
Carbomer, Ciprofloxacin hydrochloride, Ethyl cellulose, Microsphere, MucoadhesiveAbstract
Background: Ciprofloxacin hydrochloride (CH) is an antibiotic used to treat urinary tract infections. CH has a short half-life and low bioavailability. Microspheres combined with a mucoadhesive system can increase the residence time of the drug in the stomach to increase the bioavailability of CH.
Objective: This research was conducted to obtain the best amount of carbomer as a polymer mucoadhesive and ethyl cellulose as a matrix polymer based on factorial design.
Method: The factorial design 22 was used to determine the amount of carbomer and ethyl cellulose to produce optimum mucoadhesive microspheres. Three responses were observed in this study: particle size, entrapment efficiency, and mucoadhesive strength.
Result: The resulting entrapment efficiency was 69.0%, particle size was 404.52 nm, and mucoadhesive strength was 64.3 grams, with drug loading and yield values of 19.13% and 99.8%, respectively.
Conclusion: The optimum formula with the highest response value is the formula containing 300 mg carbomer and 1000 mg ethyl cellulose.
References
Begg, E.J., Robson, R.A., Saunders, D.A., Graham, G.G., Buttimore, R.C., Neill, A.M. & Town, G.I. (2000). The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing. British Journal of Clinical Pharmacology. 49(1):32–38 https://doi.org/10.1046/j.1365-2125.2000.00105.x
Brown PD. (2006). Ciprofloxacin for the Management of Urinary Tract Infection. Women’s Health, 2(4):509-516 https://doi.org/10.2217/17455057.2.4.509
Carvalho, F.C., Bruschi, M.L., Evangelista, R.C. & Gremião, M.P.D. (2010). Mucoadhesive drug delivery systems. Brazilian Journal of Pharmaceutical Sciences, 46(1):1–17 https://doi.org/10.1590/S1984-82502010000100002
Deb, J., Venkateswarlu B.S., Ghosh A., Choudhuri T., Paul P. & Faizi M. (2011) Formulation and evaluation of carbopol microspheres of metformin HCl. Asian Journal of Biomedical and Pharmaceutical Sciences, 1(2):11–19 https://www.researchgate.net/publication/275521113
Kaurav, H., Kumar, H.S.L. & Kaur, A. (2012) Mucoadhesive microspheres as carriers in drug delivery: A review. International Journal of Drug Development and Research. 4(2):21–34 https://www.itmedicalteam.pl/articles/mucoadhesive-microspheres-as-carriers-in-drug-delivery-a-review-100755.html
Kyada, C., Ranch, K. & Shah, D. (2014) Optimisation of mucoadhesive microspheres of acyclovir by applying 32 full factorial designs. Journal of Drug Delivery Science and Technology. 24(1):61–68 https://doi.org/10.1016/S1773-2247(14)50009-3
Makwana, A., Sameja, K., Parekh, H. & Pandya, Y. (2012) Advancements in controlled release gastro-retentive drug delivery system: A review. Journal of Drug Delivery and Therapeutics. 2(3):12–21 https://doi.org/10.22270/jddt.v2i3.164
Olivera, M., Manzo, R., Junginger, H., Midha, K., Shah, V., Stavchansky, S., Dressman, J. & Barends, D. (2010) Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride. Journal of Pharmaceutical Sciences, 99(5):2386–2398 https://doi.org/10.1002/jps.22259
Shahidulla, S. & S. Fatima. (2019) Formulation and in-vitro evaluation of ciprofloxacin hydrochloride mucoadhesive microspheres by ionic gelation method. International Journal of Pharma Research and Health Sciences. 7(4):3032–3038 https://doi.org/10.21276/ijprhs.2019.04.04
Srivastava K, Arora A, Kataria A, Cappelleri J.C., Sadosky A, & Peterson A.M. (2013). Impact of reducing dosing frequency on adherence to oral therapies: A literature review and meta-analysis. Patient Prefer Adherence, 20(7):419-34 https://doi.org/10.2147/PPA.S44646
Thirawong, N., Nunthanid, J., Puttipipatkhachorn, S. & Sriamornsak. P. (2007) Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyser. European Journal of Pharmaceutics and Biopharmaceutics, 67(1):132–140 https://doi.org/10.1016/j.ejpb.2007.01.010